- Manhattan Associates has narrowed its full-year revenue forecast to $1.04 billion.
- The company’s third-quarter adjusted earnings per share (EPS) were $1.35, a substantial increase from $1.05 year-over-year, surpassing the estimate of $1.07.
- Third-quarter revenue was reported at $266.7 million, marking a 12% increase compared to the previous year, beating the estimate of $263.7 million.
- Cloud Subscription revenue increased by 33% year-over-year, reaching $86.5 million, which exceeded the estimate of $85.3 million.
- Software License revenue slightly decreased by 2.8% year-over-year to $3.76 million, surpassing the estimate of $1.85 million.
- Services revenue was up by 7.1% year-over-year, amounting to $137.0 million, slightly above the estimate of $136.3 million.
- The stock is currently recommended with 7 buys, 2 holds, and 1 sell.
A look at Manhattan Associates Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Manhattan Associates, Inc. is looking solid for the long term according to Smartkarma Smart Scores. With a strong Growth score of 4, the company is poised for expansion and development. Alongside a Resilience score of 5, Manhattan Associates shows robustness in the face of challenges, indicating a steady path forward even in uncertain times.
Furthermore, Manhattan Associates demonstrates impressive Momentum with a score of 5, reflecting positive trends and market confidence. Although the Value and Dividend scores are lower, at 2 and 1 respectively, the company’s overall outlook appears promising, driven by its growth, resilience, and momentum in providing essential IT solutions for optimizing supply chain operations.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
